| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.25 | 7e-07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.27 | 8e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |